Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
1999-07-20
2003-04-15
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
Reexamination Certificate
active
06548058
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to the field of cell culture of human keratinocyte precursor and dermal fibroblast cells. In addition, the present invention also relates to the use of cultured keratinocyte precursor cells in the repair of skin defects by skin grafting procedures.
BACKGROUND OF THE INVENTION
The healing of skin defects progresses through three general phases: (i) inflammation, (ii) wound cell migration and mitosis, and (iii) extracellular matrix production and remodeling. The ordered sequence of these events is thought to be orchestrated by interactions among cells, growth factors, and extracellular matrix proteins. A crucial step of skin wound healing is epidermal regeneration (i.e., re-epithelialization). Besides interfollicular epidermal keratinocytes from the wound edges, the outer root sheath (ORS) cells from residual hair follicles also contribute to this process. See e.g., Eisen, et al., 1955
. J. Invest. Dermatol
. 15: 145-155. The ORS of hair follicles is comprised largely of undifferentiated keratinocytes that encompass the cylindrical structures of the hardened inner root sheath and the hair shaft. See e.g., Montagna and Parakkal, 1974. pp. 172-258. In:
The Structure and Function of Skin
(Academic Press New York, N.Y. Recent literature has also indicated that ORS cells are at a lower level of commitment to differentiation than the basal interfollicular keratinocytes (see e.g., Coulombe, et al., 1989
. J Cell Biol
. 109: 2295-2312; Limat, et al., 1991
. Exp. Cell Res
. 194: 218-227; Limat, et al., 1994
. Cell Tissue Res
. 275: 169-176 1994), and label-retaining cells have been detected in the animal as well as the human ORS region near the bulge area which possibly represent stem cells for skin epithelial tissues. See e.g., Cotsarelis, et al., 1990
. Cell
61: 1329-1337; Kobayashi, et al., 1993
. Proc. Natl. Acad. Sci
. USA 90: 7391-7395; Yang, et al., 1993
. J. Invest. Dermatol
. 105: 14-21; Rochat, et al., 1994
. Cell
76: 1073-1076; Moll, 1995
. J. Invest. Dermatol
. 105: 14-21. Additionally, human ORS cells which are isolated from plucked anagen scalp hair follicles can be expanded extensively in vitro. See e.g., Weterings, et al., 1981
. Brit. J. Dermatol
. 104: 1-5; Limat and Noser, 1986
. J. Invest. Dermatol
. 87: 485-488; Imcke, et al., 1987
. J. Am. Acad. Dermatol
. 17: 779-786; Limat, et al., 1989
. J. Invest. Dermatol
. 92: 758-762. Under conventional submerged culture conditions, ORS cells resemble interfollicular epidermal keratinocytes by both morphologic and biochemical (e.g., keratin profiles) criteria. See e.g., Stark, et al., 1987
. Differentiation
35: 236-248; Limat, et al., 1989
. J. Invest. Dermatol
. 92: 758-762; Limat, et al., 1991
. Ann. N.Y. Acad. Sci
. 642: 125-147. In organotypic co-cultures with human dermal fibroblasts (i.e., under conditions mimicking the epidermal environment), ORS cells with respect to histological, immunohistological, ultrastructural and biochemical criteria develop a stratified epithelium reminiscent of regenerating epidermis. See e.g., Lenoir, et al., 1988
. Dev. Biol
. 130: 610-620; Limat, et al., 1991
. Exp. Cell Res
. 194: 218-227; Limat, et al., 1991
. Ann. N.Y. Acad. Sci
. 642: 125-147. If such organotypic cultures are grafted onto nude mice, ORS cells form a regular neo-epidermis that is under homeostatic control. See e.g., Limat, et al., 1995
. Transplantation
59: 1032-1038. Thus, human ORS cells are of considerable interest for clinical application.
In the previous decade, interest has focused on the use of cultured epithelial cells for wound coverage. First, sheets of cultured autologous interfollicular keratinocytes were grafted successfully on acute wounds, mainly in the treatment of larger third degree burns (see e.g., O'Connor, et al., 1981
. Lancet
1: 75-78; Compton, et al., 1989
. Lab. Invest
. 60: 600-612) but also of epidermolysis bullosa (see e.g., Carter, et al., 1987
. J. Am. Acad. Dermatol
. 17: 246-250), pyoderma gangrenosum (see e.g., Dean, et al., 1991
. Ann. Plast. Surg
. 26: 194-195; Limova and Mauro, 1994
. J. Dermatol. Surg. Oncol
. 20: 833-836), and wounds after excision of giant congenital nevi (see e.g., Gallico, et al., 1989
. J. Plast. Reconstr. Surg
. 84: 1-9) or separation of conjoined twins (see e.g., Higgins, et al., 1994
. J. Royal Soc. Med
. ??:108-109).
In contrast to the treatment of such acute wounds, the grafting of chronic wounds (e.g., leg ulcers) with cultured keratinocytes has been much less successful. Allografts do not result in a permanent “take” (see e.g., Fabre, 1991
. Immunol. Lett
. 29: 161-166) and thus may be classified as a “ . . . quite effective but expensive biological dressing”. See Phillips, et al., 1989
. J Am. Acad. Dermatol
. 21: 191-199. A reproducible, major definite “take” of autologous keratinocyte grafted by various modalities including: sheets of submerged keratinocyte cultures consisting of only a few, noncornified cell layers (Hetton, et al., 1986
. J. Am. Acad. Dermatol
. 14: 399-405; Leigh and Purkis, 1986
. Clin. Exp. Dermatol
. 11: 650-652; Leigh, et al., 1987
. Brit. J. Dermatol
. 117: 591-597; Harris, et al., 1993
. Clin. Exp. Dermatol
. 18: 417-420), trypsinized single cells attached to collagen-coated dressings (Brysk, et al., 1991
. J. Am. Acad. Dermatol
. 25: 238-244), skin equivalents (Mol, et al., 1991
. J. Am. Acad. Dermatol
. 24: 77-82, 1991) has yet to be convincingly documented within the scientific literature. The same lack of quantitative findings also holds true for various reports on the grafting of freshly isolated, autologous interfollicular keratinocytes (Hunyadi, et al., 1988
. J. Dermatol. Surg. Oncol
. 14: 75-78) or ORS cells (Moll, et al., 1995
. Hautarzt
46: 548-552) fixed to the wound bed by the use of a fibrin glue. However, it should be noted that the disadvantages of the bovine serum used during cultivation of the keratinocytes may contribute to reduced “take” rate, due to the fact that it resists in keratinocytes. See e.g., Johnson, et al., 1990
. J. Burn Care Rehab
. 11: 504-509.
SUMMARY OF THE INVENTION
Prior to the disclosure of the present invention herein, the standard methodology for the generation of a primary culture of basal keratinocytes consisted of the plucking of an anagenic (i.e., growing hair shaft) hair followed by a careful microscopic dissection to remove the hair bulbs and the infundibular hair shaft. The resulting outer root sheath (ORS) was then placed on the culture insert for initiation of the primary keratinocyte culture. However, numerous subsequent studies (approximately 200), wherein the anagenic hair was placed directly on the culture insert without performing the initial micro-dissection to remove the hair bulbs and the infundibular hair shaft, have demonstrated that such tedious and time-consuming dissection of the plucked anagenic hair was not required. This has served to markedly simplify the handling process, reduce the risk for contamination, and resulted in more efficient initiation of keratinocyte cell plating.
Accordingly, it is an object of the present invention to provide improved and simplified methods for the generation of keratinocytes or keratinocyte precursors from outer root sheath cells (ORS cells) in fully defined culture conditions for the treatment of various types of skin defects (e.g., chronic wounds such as leg ulcers, diabetic ulcers, pressure sores, and the like) in both humans and animals. In addition to their use in the treatment of wounds, keratinocytes may also be used in plastic and cosmetic surgery, or whenever there is a demand for such skin support (e.g., post operative following the removal of tattoos, naevi, skin cancer, papillomas, after amputation, in sex transformation or re-virgination, and the like).
These aforementioned objectives are accomplished by explantation and culture of plucked, anagenic or growing hairs in toto upon microporous membranes carrying human fibroblast feeder cells at their under-surface. In such primary cultures, large numbers of ORS cells can be easily and repea
Hunziker Thomas
Limat Alain
Elrifi, Esq. Ivor R.
Epitech, S.A.
Karnakis, Esq. Christina V.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Witz Jean C.
LandOfFree
Keratinocyte culture and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keratinocyte culture and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keratinocyte culture and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3090079